NCT06778304
- Conditions
- Bioequivalence, Healthy Volunteers, Immunogenicity, +2 more
- Locations
-
- West China Second University Hospital Chengdu, Sichuan, China
Clinical trial condition
Bioequivalence
Explore clinical trials studying Bioequivalence. Study availability and eligibility vary by location and protocol.
140 public trials
1 recruiting study
Bioequivalence trial results
NCT05014490
- Conditions
- Bioequivalence, Healthy Subjects
- Locations
-
- Erciyes University Hakan Çetinsaya İyi Klinik Uygulama ve Arastirma Merkezi, IKUM (Center for GCP) Kayseri, Turkey (Türkiye)
NCT06563856
- Conditions
- Autoimmune Diseases, Bioavailability, Bioequivalence, +13 more
- Locations
-
- PPD Development Las Vegas, Nevada, United States
NCT06331715
- Conditions
- Bioequivalence
- Locations
-
- Azidus Laboratories Chennai, India
Completed
Bioequivalence Study of GP30101 800 mg (GEROPHARM) Versus PREZISTA® 800 mg ("Jonson&Jonson", Russia)
NCT04268472
- Conditions
- Bioequivalence
- Locations
-
- Yarosslavl Clinical Hospital #3 Yaroslavl, Russia
NCT06497049
- Conditions
- Bioequivalence, Pharmacokinetics, Safety Issues
- Locations
-
- Yarosslavl Clinical Hospital #3 Yaroslavl, Russia
Completed
Rivastigmine Bioequivalence Trial With Multiple Applications of Transdermal Patches (9.5 mg/24 h)
NCT05883124
- Conditions
- Bioequivalence
- Locations
-
- SocraTec R&D GmbH, Clinical Pharmacology Unit Erfurt, Thuringia, Germany
Completed
Bioavailability Study in Healthy Participants, 200mg Tablets ZSP1273 Versus 200mg Granules ZSP1273
NCT06164431
- Conditions
- Bioequivalence
- Locations
-
- Guangdong Hospital of Chinese Medicine Guangzhou, Guangdong, China
NCT05642845
- Conditions
- Bioequivalence
- Locations
-
- State Budgetary Healthcare Institution of the Yaroslavl Region "Clinical Hospital No. 2" Yaroslavl, Russia
NCT05685277
- Conditions
- Bioequivalence
- Locations
-
- Separate medical division "Comed" (Ligand Research LLC) Moscow, Russia